Why the study?
Does renal transplantation improve left ventricular systolic dysfunction and uremic cardiomyopathy in patients with chronic kidney disease?
Does renal transplantation improve left ventricular systolic dysfunction and uremic cardiomyopathy in patients with chronic kidney disease?
Renal transplantation may reverse severe left ventricular systolic dysfunction and improve uremic cardiomyopathy, challenging the historical view that severe LV dysfunction is an absolute contraindication to transplant.
May support transplant in severe LV dysfunction; leaves open prospective confirmation of uremic cardiomyopathy reversal.
Chronic heart failure (CHF) and chronic kidney disease (CKD) are serious medical conditions with significant morbidity and mortality. Emerging evidence indicates that the function of these two organ systems are affected by each other in a complex interplay. Most patients with CKD suffer frequently from cardiac abnormalities including left ventricular hypertrophy (LVH), left ventricular dilatation (LVD), left ventricular (LV) diastolic and/or systolic dysfunction. Although previously thought that LV systolic dysfunction was an absolute contraindication to renal transplantation, several observational studies have shown this not to be true and that transplantation can lead to significant improvement in LV systolic function. Furthermore, correction of the uremic state by renal transplantation leads to improvement of LVD and possibly regression of LVH. In fact, the reduction of LVH postkidney transplantation was shown to be dependent on adequate renal function and hypertension control. Diabetes mellitus does not seem to be a confounding factor in the improvement of uremic cardiomyopathy with renal transplantation.
No takes yet. Share an insight, caveat, or question.
Zolty et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: